Ergomed plc (LSE: ERGO) (“Ergomed” or the “Company”), a company focused on providing specialised services to the pharmaceutical industry, today announces the acquisition of Ashfield Pharmacovigilance Inc. (“Ashfield PV”), a specialist pharmacovigilance services provider based in Cary in the Research Triangle, North Carolina, USA (the “Acquisition”) from UDG Healthcare US Holdings, Inc., the US operating subsidiary of UDG Healthcare plc (“UDG” or the “Seller”). Ergomed has acquired the entire issued share capital of Ashfield PV for a total cash consideration of $10 million.
Read the full article: Ergomed Reports Acquisition of Ashfield Pharmacovigilance Inc. //
Source: https://www.ergomedplc.com/acquisition-of-ashfield-pharmacovigilance-inc-a-us-pharmacovigilance-services-provider-from-udg-healthcare-for-10-million